Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 28, 2010; 16(28): 3521-3528
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3521
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3521
Figure 3 Down-expression of various molecules in glypican-3 siRNA-transfected hepatocellular carcinoma cell line.
A: mRNA levels analyzed by real-time reverse transcription-polymerase chain reaction. The mRNA expressions of matrix metalloproteinase (MMP)2, MMP14, fibroblast growth factor receptor 1 (FGFR1), and insulin-like growth factor 1 receptor (IGF1R) were significantly down-regulated in HepG2 cells treated with glypican-3 (GPC3) specific siRNA (P < 0.05). Bar: SE; B: Protein levels analyzed by immunoblotting. The protein expressions of MMP2, MMP14, FGFR1, and IGF1R were significantly down-regulated in HepG2 cells treated with GPC3 specific siRNA; C: MMP2 activity analyzed by gelatin zymography. Conditioned media of siRNA-transfected HepG2 were used for gelatin zymography.
- Citation: Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K, Shinomura Y. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. World J Gastroenterol 2010; 16(28): 3521-3528
- URL: https://www.wjgnet.com/1007-9327/full/v16/i28/3521.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i28.3521